Skip to main content

What the FDA labels say about taking them together

Loperamide and sevabertinib

Sevabertinib's FDA label of March 4, 2026 names loperamide in its warnings and precautions section; the loperamide label PlainMeds reads does not name sevabertinib. The sevabertinib label: “At the first sign of diarrhea or increased bowel movement frequency, instruct patients to start an antidiarrheal treatment, and to increase their fluid and electrolyte intake.”

Check it at the source: the loperamide FDA label on DailyMed (effective June 3, 2026, Aurobindo Pharma Limited); the sevabertinib FDA label on DailyMed (effective March 4, 2026, Bayer HealthCare Pharmaceuticals Inc.).

What does the loperamide label say about sevabertinib?

Loperamide's label (effective June 3, 2026) does not name sevabertinib in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Loperamide Hydrochloride), Aurobindo Pharma Limited, effective June 3, 2026 (SPL set 8e4004be-bf79-4631-9e38-c4e7b6726313), via openFDA; the full label on DailyMed

What does the sevabertinib label say about loperamide?

Sevabertinib label, warnings and precautions

At the first sign of diarrhea or increased bowel movement frequency, instruct patients to start an antidiarrheal treatment (e.g., loperamide [refer to full Prescribing Information] ), and to increase their fluid and electrolyte intake.

Source: FDA drug label (HYRNUO), Bayer HealthCare Pharmaceuticals Inc., effective March 4, 2026 (SPL set d7a11334-6e7a-445b-9a16-bdcd9acbe61f), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

95Loperamide generic labelers
0Sevabertinib generic labelers
LoperamideSevabertinib
Labeled forDiarrheaLung cancer
Boxed warningYesNo
Pharmacy cost (NADAC)$0.0549 per capsule 2 mg capsulen/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?